SEC Filing Details
Document Details
Form
Filing Date
Mar 3, 2021
Document Date
Mar 1, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Ultragenyx Pharmaceutical Inc.
Issuer
Ultragenyx Pharmaceutical Inc.
Filer
Kassberg Thomas Richard